ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
CDC recommends PaxVax’s Vaxchora for travelers to cholera-affected regions
May 18, 2017Privately held PaxVax is getting a boost for its cholera vaccine with the U.S. Centers for Disease Control and Prevention now recommending Vaxchora for adults aged 18 to 64 traveling to areas where cholera is active. Vaxchora is the only FDA-approved chol
Pharma Sources Insight January 2025
